Can weight loss improve facial hyperpigmentation? | Rounds Can weight loss improve facial hyperpigmentation? | Rounds
Loading...

Can weight loss improve facial hyperpigmentation?

Medical Advisory Board
All articles are reviewed for accuracy by our Medical Advisory Board.

Educational purpose only · Not a substitute for professional judgment or the full text of guidelines and labels.

Article Review Status
Submitted
Under Review
Approved

Last updated: July 14, 2026 · View editorial policy

Weight loss and facial hyperpigmentation

Weight loss can improve hyperpigmentation when the pigmentation is caused by obesity-related insulin resistance, particularly acanthosis nigricans. Evidence for weight loss improving other common causes of facial hyperpigmentation (eg, melasma or post-inflammatory hyperpigmentation) is limited.

Conditions with stronger evidence for improvement

Acanthosis nigricans

Acanthosis nigricans is a form of hyperpigmentation associated with insulin resistance. Weight loss after bariatric surgery is associated with high remission rates of acanthosis nigricans skin lesions. [1]

Mechanistic linkage

Weight loss improves insulin resistance, which is central to the pathophysiology of acanthosis nigricans-associated skin changes. [2]

Conditions with limited direct evidence

Melasma

No high-quality evidence was identified in the retrieved literature showing that weight loss alone improves melasma. [No direct weight-loss-specific melasma trial evidence retrieved.]

Post-inflammatory hyperpigmentation

No high-quality evidence was identified in the retrieved literature showing that weight loss alone improves post-inflammatory hyperpigmentation. [No direct weight-loss-specific PIH trial evidence retrieved.]

Clinical approach to deciding whether weight loss may help

  • If hyperpigmentation is associated with obesity-related insulin resistance features, weight loss is more likely to improve the condition. [1]
  • If hyperpigmentation is consistent with melasma or post-inflammatory hyperpigmentation, evidence supports standard dermatologic therapies more than weight loss alone. [No direct weight-loss-specific evidence retrieved.]
  • Presence of acanthosis nigricans distribution (often in intertriginous areas) and clinical context of obesity-associated insulin resistance supports weight-loss-oriented management. [1]

Safety and follow-up considerations

  • Bariatric or intensive weight-loss interventions should be managed medically due to potential systemic effects and need for longitudinal follow-up. [1]
  • Skin response can lag behind metabolic improvement, so reassessment should occur over months rather than weeks after weight-loss interventions. [1]

Related Questions